Maria M Caffarel
@mariacaffarel.bsky.social
Cancer researcher interested in breast cancer, cytokines and the tumour microenvironment. Ikerbasque Research Associate. Group leader at @biogipuzkoa.bsky.social @aseica.bsky.social
Pinned
Last week, we had a fantastic lab retreat! Thanks everything for the fun and the great science! Looking forward to an exciting new year together!
Reposted by Maria M Caffarel
Aquí van algunos ejemplos (incluido el tuyo 😉). Pero por subáreas, que es lo que aparece en la tabla del Ministerio.
bsky.app/profile/jaes...
bsky.app/profile/jaes...
Me preguntan por la financiación de distintas áreas. Son muchas...
Aquí pongo de ejemplo una humanidades (Historia), una de ciencias "básicas" (Química) y una de biomedicina (Cáncer). La financiación media varía mucho, claro, pero el raquitismo relativo se mantiene... 😕
Aquí pongo de ejemplo una humanidades (Historia), una de ciencias "básicas" (Química) y una de biomedicina (Cáncer). La financiación media varía mucho, claro, pero el raquitismo relativo se mantiene... 😕
July 30, 2025 at 2:19 PM
Aquí van algunos ejemplos (incluido el tuyo 😉). Pero por subáreas, que es lo que aparece en la tabla del Ministerio.
bsky.app/profile/jaes...
bsky.app/profile/jaes...
Reposted by Maria M Caffarel
@megeblad.bsky.social once more revealing significant cancer biology - Congrats!
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Neutrophils drive vascular occlusion, tumour necrosis and metastasis - Nature
Neutrophils actively induce tumour necrosis, driving vascular occlusion, pleomorphic necrosis and metastasis.
www.nature.com
July 23, 2025 at 5:44 PM
@megeblad.bsky.social once more revealing significant cancer biology - Congrats!
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Reposted by Maria M Caffarel
🔬 El grupo #CáncerdeMama de #Biogipuzkoa ha analizado la posibilidad de que existan genes que pueden utilizarse para predecir la respuesta al tratamiento endocrino previo a la cirugía en las pacientes con cáncer de mama luminal.
📝 https://f.mtr.cool/oiaoddswvc
📝 https://f.mtr.cool/oiaoddswvc
July 22, 2025 at 8:02 AM
🔬 El grupo #CáncerdeMama de #Biogipuzkoa ha analizado la posibilidad de que existan genes que pueden utilizarse para predecir la respuesta al tratamiento endocrino previo a la cirugía en las pacientes con cáncer de mama luminal.
📝 https://f.mtr.cool/oiaoddswvc
📝 https://f.mtr.cool/oiaoddswvc
Reposted by Maria M Caffarel
I’m happy to share our latest work on tumour necrosis! During my time in the @megeblad.bsky.social lab, we found that tumour necrosis is not a passive phenomenon secondary to tumour growth, but an active phenomenon driven by neutrophils and NETs! Thread below: (1/13)
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Neutrophils drive vascular occlusion, tumour necrosis and metastasis - Nature
Neutrophils actively induce tumour necrosis, driving vascular occlusion, pleomorphic necrosis and metastasis.
www.nature.com
July 17, 2025 at 11:28 AM
I’m happy to share our latest work on tumour necrosis! During my time in the @megeblad.bsky.social lab, we found that tumour necrosis is not a passive phenomenon secondary to tumour growth, but an active phenomenon driven by neutrophils and NETs! Thread below: (1/13)
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Reposted by Maria M Caffarel
🚀 Discover the latest breakthroughs in cancer research!
The July 2025 Highlights in Cancer Research features 10 standout papers, including insights into lung cancer progression and chemo sensitivity linked to the oestrous cycle.
Read more: magazine.eacr.org/highlights-i...
The July 2025 Highlights in Cancer Research features 10 standout papers, including insights into lung cancer progression and chemo sensitivity linked to the oestrous cycle.
Read more: magazine.eacr.org/highlights-i...
July 16, 2025 at 11:03 AM
🚀 Discover the latest breakthroughs in cancer research!
The July 2025 Highlights in Cancer Research features 10 standout papers, including insights into lung cancer progression and chemo sensitivity linked to the oestrous cycle.
Read more: magazine.eacr.org/highlights-i...
The July 2025 Highlights in Cancer Research features 10 standout papers, including insights into lung cancer progression and chemo sensitivity linked to the oestrous cycle.
Read more: magazine.eacr.org/highlights-i...
Reposted by Maria M Caffarel
A fresh virtual event spotlighting cutting-edge immunotherapies => be at the forefront of innovation. Do not miss it!
Registration and abstract submission is open for Next Generation Immunotherapies!
Join us online next February to explore cutting-edge developments in immunotherapy, ranging from basic research to clinical applications.
Learn more: eacr.org/conference/n...
Join us online next February to explore cutting-edge developments in immunotherapy, ranging from basic research to clinical applications.
Learn more: eacr.org/conference/n...
July 9, 2025 at 9:31 PM
A fresh virtual event spotlighting cutting-edge immunotherapies => be at the forefront of innovation. Do not miss it!
Do not miss this beautiful work on TIM3 and immune evasion and micrometastasis just published in @cp-cancercell.bsky.social by @tceliaterrassa.bsky.social lab! Congrats my dear friend!
We’re thrilled to share our latest publication in
@cp-cancercell.bsky.social and very proud of C. Rozalén for this tour de force uncovering how TIM3⁺ breast cancer cells drive immune evasion during micrometastasis. #CancerImmunology #BreastCancer #Metastasis www.cell.com/cancer-cell/...
@cp-cancercell.bsky.social and very proud of C. Rozalén for this tour de force uncovering how TIM3⁺ breast cancer cells drive immune evasion during micrometastasis. #CancerImmunology #BreastCancer #Metastasis www.cell.com/cancer-cell/...
TIM3+ breast cancer cells license immune evasion during micrometastasis outbreak
Rozalén et al. report that TIM3 in breast cancer drives a specific mechanism of immune
escape during micrometastasis. TIM3+ tumor cells exhibit stemness/EMT features and
promote immune-evasion by indu...
www.cell.com
July 14, 2025 at 5:43 AM
Do not miss this beautiful work on TIM3 and immune evasion and micrometastasis just published in @cp-cancercell.bsky.social by @tceliaterrassa.bsky.social lab! Congrats my dear friend!
Congrats @emlecona.bsky.social and team! Beautiful work! Many more to come from this great lab!
Very happy to share our recently published work on the role of VCP/p97 during DNA replication.
Just published!
Lecona (@emlecona.bsky.social ) & Méndez #RepliFate labs show that VCP/p97 removes Pol α/primase from chromatin to avoid excess ATR activation during normal #DNAreplication
VCP/p97 = checkpoint gatekeeper!
Read the full study: doi.org/10.1038/s414...
Lecona (@emlecona.bsky.social ) & Méndez #RepliFate labs show that VCP/p97 removes Pol α/primase from chromatin to avoid excess ATR activation during normal #DNAreplication
VCP/p97 = checkpoint gatekeeper!
Read the full study: doi.org/10.1038/s414...
July 14, 2025 at 5:40 AM
Congrats @emlecona.bsky.social and team! Beautiful work! Many more to come from this great lab!
Reposted by Maria M Caffarel
Extremely happy and proud to share with you all our last article in @CR_AACR on the prometastatic role of PPAR-delta in pancreatic cancer. Check it out here:
aacrjournals.org/cancerres/ar...
aacrjournals.org/cancerres/ar...
PPAR-δ Orchestrates a Pro-metastatic Metabolic Response to Microenvironmental Cues in Pancreatic Cancer
Abstract. The pronounced desmoplastic response in pancreatic ductal adenocarcinoma (PDAC) contributes to the development of a microenvironment depleted of oxygen and nutrients. To survive in this host...
aacrjournals.org
July 4, 2025 at 9:36 AM
Extremely happy and proud to share with you all our last article in @CR_AACR on the prometastatic role of PPAR-delta in pancreatic cancer. Check it out here:
aacrjournals.org/cancerres/ar...
aacrjournals.org/cancerres/ar...
Reposted by Maria M Caffarel
🩷 Hoy hemos recibido a las voluntarias de #MaitetaBizi y nos han hecho entrega del cheque de 7.000€.
El dinero será destinado a las líneas del grupo de #CancerdeMama de #Biogipuzkoa liderado por @mariacaffarel.bsky.social e Isabel Álvarez.
🤲 ¡Muchas gracias, seguimos investigando juntas!
El dinero será destinado a las líneas del grupo de #CancerdeMama de #Biogipuzkoa liderado por @mariacaffarel.bsky.social e Isabel Álvarez.
🤲 ¡Muchas gracias, seguimos investigando juntas!
July 1, 2025 at 12:37 PM
🩷 Hoy hemos recibido a las voluntarias de #MaitetaBizi y nos han hecho entrega del cheque de 7.000€.
El dinero será destinado a las líneas del grupo de #CancerdeMama de #Biogipuzkoa liderado por @mariacaffarel.bsky.social e Isabel Álvarez.
🤲 ¡Muchas gracias, seguimos investigando juntas!
El dinero será destinado a las líneas del grupo de #CancerdeMama de #Biogipuzkoa liderado por @mariacaffarel.bsky.social e Isabel Álvarez.
🤲 ¡Muchas gracias, seguimos investigando juntas!
Reposted by Maria M Caffarel
A huge thank you to all participants, speakers and organisers of this week's Early Career Researchers' Conference! Always a favourite of ours in the EACR virtual conference calendar 😊
June 26, 2025 at 8:59 AM
A huge thank you to all participants, speakers and organisers of this week's Early Career Researchers' Conference! Always a favourite of ours in the EACR virtual conference calendar 😊
Reposted by Maria M Caffarel
Are you looking to start your #lab in a fantastic scientific 🧪environment, with great colleagues, and in a spectacular place to live?
Then check out our open #junior #faculty position at the Department of Oncology, University of Lausanne, Switzerland:
www.unil.ch/dof/en/home/...
⏰ Deadline 27 June
Then check out our open #junior #faculty position at the Department of Oncology, University of Lausanne, Switzerland:
www.unil.ch/dof/en/home/...
⏰ Deadline 27 June
June 23, 2025 at 5:14 PM
Are you looking to start your #lab in a fantastic scientific 🧪environment, with great colleagues, and in a spectacular place to live?
Then check out our open #junior #faculty position at the Department of Oncology, University of Lausanne, Switzerland:
www.unil.ch/dof/en/home/...
⏰ Deadline 27 June
Then check out our open #junior #faculty position at the Department of Oncology, University of Lausanne, Switzerland:
www.unil.ch/dof/en/home/...
⏰ Deadline 27 June
Very grateful as well for the amazing science and fun with friends from @biogipuzkoa.bsky.social @aseica.bsky.social @helloeacr.bsky.social #ECRcouncil
June 19, 2025 at 1:16 PM
Very grateful as well for the amazing science and fun with friends from @biogipuzkoa.bsky.social @aseica.bsky.social @helloeacr.bsky.social #ECRcouncil
On my way home after a great #EACR2025 conference in Lisbon. Thanks @helloeacr.bsky.social for the oppurtunity to present our work from @biogipuzkoa.bsky.social and for the Travel Fellowship to @peioazcoaga.bsky.social !
June 19, 2025 at 1:12 PM
On my way home after a great #EACR2025 conference in Lisbon. Thanks @helloeacr.bsky.social for the oppurtunity to present our work from @biogipuzkoa.bsky.social and for the Travel Fellowship to @peioazcoaga.bsky.social !
Reposted by Maria M Caffarel
It’s hard to believe #EACR2025 is almost over! Huge thanks from the EACR Congress team to everyone who made it so special. And to those following along from home - we hope to welcome you in person next year!
June 19, 2025 at 8:56 AM
It’s hard to believe #EACR2025 is almost over! Huge thanks from the EACR Congress team to everyone who made it so special. And to those following along from home - we hope to welcome you in person next year!
Reposted by Maria M Caffarel
So grateful for the opportunity to present our project from amazing Caffarel Lab @mariacaffarel.bsky.social in such a great #EACR2025 Congress @helloeacr.bsky.social 🤩👏🔝
June 16, 2025 at 10:48 PM
So grateful for the opportunity to present our project from amazing Caffarel Lab @mariacaffarel.bsky.social in such a great #EACR2025 Congress @helloeacr.bsky.social 🤩👏🔝
Great talk by #MatheusdosSantosDias at the @helloeacr.bsky.social cancer researchers to watch symposium! Good luck with your new adventure as PI at the #princesMaximaCenter! 🍀
June 15, 2025 at 4:36 PM
Great talk by #MatheusdosSantosDias at the @helloeacr.bsky.social cancer researchers to watch symposium! Good luck with your new adventure as PI at the #princesMaximaCenter! 🍀
Reposted by Maria M Caffarel
@helloeacr.bsky.social #EACR2025 Cancer Researcher s to Watch Event is on!!!! by @mariacaffarel.bsky.social 👏👏
June 15, 2025 at 1:09 PM
@helloeacr.bsky.social #EACR2025 Cancer Researcher s to Watch Event is on!!!! by @mariacaffarel.bsky.social 👏👏
Reposted by Maria M Caffarel
Amazing talk by Prof María Caffarel @mariacaffarel.bsky.social at the @helloeacr.bsky.social #EACR2025 Beautiful work!! cytokines rock 👏👏👏🤩
June 15, 2025 at 3:36 PM
Amazing talk by Prof María Caffarel @mariacaffarel.bsky.social at the @helloeacr.bsky.social #EACR2025 Beautiful work!! cytokines rock 👏👏👏🤩
Congrats @peioazcoaga.bsky.social 👏🏻👏🏻👏🏻
So happy to be selected as a congress correspondent 😄 and to be part of the @helloeacr.bsky.social community!! Many thanks!! Amazing #EACR2025 Congress ahead, really looking forward ;) 👏🙌
May 31, 2025 at 6:20 AM
Congrats @peioazcoaga.bsky.social 👏🏻👏🏻👏🏻
If interested in cancer-associated fibroblasts, please apply! Great science and great PI! 👇🏽
JOB ALERT!! 🧪 We are offering a postdoc position within our “antiCAFing” ERC-CoG project to investigate the interplay CAFs:endothelial cells and its impact in aberrant vascularization in tumors. More details below 👇. Please spread the word.
May 27, 2025 at 2:20 PM
If interested in cancer-associated fibroblasts, please apply! Great science and great PI! 👇🏽
Reposted by Maria M Caffarel
JOB ALERT!! 🧪 We are offering a postdoc position within our “antiCAFing” ERC-CoG project to investigate the interplay CAFs:endothelial cells and its impact in aberrant vascularization in tumors. More details below 👇. Please spread the word.
May 23, 2025 at 1:17 PM
JOB ALERT!! 🧪 We are offering a postdoc position within our “antiCAFing” ERC-CoG project to investigate the interplay CAFs:endothelial cells and its impact in aberrant vascularization in tumors. More details below 👇. Please spread the word.
Thank you @idibell.bsky.social and @rrodriguezbarrueco.bsky.social for the invitation! It has been a great day of scientific discussions and friendship. @elisaespinet.bsky.social @txellrovira.bsky.social
Looking forward to exciting new collaborations 🧬🔬💊
Looking forward to exciting new collaborations 🧬🔬💊
May 16, 2025 at 8:49 PM
Thank you @idibell.bsky.social and @rrodriguezbarrueco.bsky.social for the invitation! It has been a great day of scientific discussions and friendship. @elisaespinet.bsky.social @txellrovira.bsky.social
Looking forward to exciting new collaborations 🧬🔬💊
Looking forward to exciting new collaborations 🧬🔬💊
Now is the turn of #AnaJanic describing new therapeutic strategies to promote immunogenicity in the @helloeacr.bsky.social conference Defence is the best attack. Congrats Ana! Beautiful work!
May 14, 2025 at 3:44 PM
Now is the turn of #AnaJanic describing new therapeutic strategies to promote immunogenicity in the @helloeacr.bsky.social conference Defence is the best attack. Congrats Ana! Beautiful work!
Reposted by Maria M Caffarel
Are you attending the 2025 'Defence is the Best Attack: Immuno-Oncology Breakthroughs' conference in Barcelona?
So is our editor Lise Roth!
Talk to her if you are looking for a home for your paper or about scientific publishing @embopress.org
@helloeacr.bsky.social
So is our editor Lise Roth!
Talk to her if you are looking for a home for your paper or about scientific publishing @embopress.org
@helloeacr.bsky.social
May 12, 2025 at 8:15 PM
Are you attending the 2025 'Defence is the Best Attack: Immuno-Oncology Breakthroughs' conference in Barcelona?
So is our editor Lise Roth!
Talk to her if you are looking for a home for your paper or about scientific publishing @embopress.org
@helloeacr.bsky.social
So is our editor Lise Roth!
Talk to her if you are looking for a home for your paper or about scientific publishing @embopress.org
@helloeacr.bsky.social